14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026
DAVA vs EPAM: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
As of Nov 17, 2026, Epam Systems, Inc. (EPAM) is the stronger overall head-to-head candidate over Endava plc (DAVA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DAVA carries a Unified Composite Score of 40.1/100 (SELL) at $1.39 (2.2x Forward P/E, 0.5% operating margin), whereas EPAM carries 32.9/100 (SELL) at $157.00 (11.3x Forward P/E, 11.4% operating margin).
Composite vs. Pillar Nuance: While DAVA currently prints a higher short-term Unified Composite Score (40.1/100 SELL vs. EPAM 32.9/100 SELL), EPAM captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.4% vs. 0.5% operating margin) and revenue trajectory (+2.3% vs. -8.4% YoY).
Defensive Composite Rating Caution: Although EPAM compares more favorably head-to-head, both DAVA (40.1/100 SELL) and EPAM (32.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.
Technical & Structure Timing Caution: DAVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4); meanwhile EPAM trades in a Markup technical trend (SURGE options phase, RSI 68.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on DAVA vs EPAM. Trailing 12-month operating profitability (DAVA 0.5% vs EPAM 11.4%) and valuation multiples (DAVA 2.2x vs EPAM 11.3x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Information Technology Services value chain with $8.3B market capitalization and 11.4% operating margin.
OpEx & R&D Reinvestment18.5% of Rev ($1.05B)
90D Engineering Disclosures0 Published
Investor FAQ DAVA vs EPAM Key Questions & Quantitative Answers
As of Nov 17, 2026, Epam Systems, Inc. (EPAM) is the stronger overall head-to-head candidate over Endava plc (DAVA) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). DAVA carries a Unified Composite Score of 40.1/100 (SELL) at $1.39 (2.2x Forward P/E, 0.5% operating margin), whereas EPAM carries 32.9/100 (SELL) at $157.00 (11.3x Forward P/E, 11.4% operating margin). Composite vs. Pillar Nuance: While DAVA currently prints a higher short-term Unified Composite Score (40.1/100 SELL vs. EPAM 32.9/100 SELL), EPAM captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.4% vs. 0.5% operating margin) and revenue trajectory (+2.3% vs. -8.4% YoY). Defensive Composite Rating Caution: Although EPAM compares more favorably head-to-head, both DAVA (40.1/100 SELL) and EPAM (32.9/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model. Technical & Structure Timing Caution: DAVA is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 28.4); meanwhile EPAM trades in a Markup technical trend (SURGE options phase, RSI 68.4). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
EPAM leads the Growth & Scale pillar: DAVA posts -8.4% YoY revenue growth and -21.4% YoY earnings growth on $728M TTM revenue (21.9% gross margin, 0.5% operating margin), compared with EPAM at +2.3% YoY revenue growth and +32.5% YoY earnings growth on $5.65B TTM revenue (29.9% gross margin, 11.4% operating margin). On trailing 12-month operating scale, DAVA generates $728M in USD-normalized revenue versus $5.65B for EPAM. In operating R&D and SG&A reinvestment, DAVA deploys 21.4% of Rev ($156M) (0 90-day corporate R&D disclosures) versus 18.5% of Rev ($1.05B) (0 disclosures) for EPAM.
DAVA screens cheaper on headline valuation multiples. DAVA trades at 2.2x Forward P/E, 2.0x Trailing P/E, 0.28x PEG, and 0.1x EV/Revenue (4.1% EBITDA margin), whereas EPAM trades at 11.3x Forward P/E, 20.5x Trailing P/E, 0.95x PEG, and 1.3x EV/Revenue (8.3% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DAVA (-99.8% ROE) versus EPAM (11.6% ROE) capital efficiency.
In options market volatility and institutional positioning, DAVA carries 57.4% implied volatility (50th %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.32β · 73% Vol realized risk). By comparison, EPAM carries 63.5% implied volatility (28th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (-0.81β · 81% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.